(Total Views: 65)
Posted On: 02/12/2021 12:00:55 PM
Post# of 89377
$ABEO News Article - New Positive Phase 1/2 Interim Data Presented at WORLDSymposium(TM) Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona's ABO-102 Gene Therapy https://marketwirenews.com/news-releases/new-...21547.html
(0)
(0)
My Twitter: WhyteStocks
